AzTrials
AzTrials

Neuropathic PainNCT04125576

Comparison of Pain-Related Changes in Cerebral Blood Volume in Burn Patients With Neuropathic Pain

An observational study of Neuropathic Pain, run by Hangang Sacred Heart Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators will observe increased or decreased CBV in patients with thermal injury compared with the CBV in healthy controls. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Neuropathic Pain
What is being tested?
magnetic resonance imaging(MRI)
How many people
50 participants
Where
1 siteSouth Korea
Study dates
25 Oct 2019to 20 Dec 2019
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The patients complained of severe neuropatic pain rated at least 5 on the 10-point numerical rating scale (NRS), despite being treated with drugs and physical therapy for more than 1 week after being admitted to the Department of Rehabilitation Medicine.

Who may be able to join

  • Burn patients
  • severe neuropatic pain rated at least 5 on the 10-point numerical rating scale (NRS).

Who cannot join

  • cardiac arrest history
  • history of neurologic disease or brain surgery
  • unstable heart disease or presence of a cardiac pacemaker
  • psychiatric disorder
  • diabetes mellitus
  • abnormal renal function
  • contraindication for MRI
  • pregnancy.

Trial locations and contacts

1 site in 1 country.

Cheong Hoon Seo, Dr. contact

+82 2 2639 5738

chseomd@gmail.com

South Korea1 site, 1 recruiting
  • Hangang Sacred Heart Hospital

    Seoul, Yeong-deungpo-Dong, 150-719

    Cheong Hoon Seo, M.D., +82 2 2639 5738, chseomd@gmail.com

    Recruiting

Other trials in South Korea

About this study

The investigators will observe increased or decreased CBV in patients with thermal injury compared with the CBV in healthy controls.

Read the detailed description

Prevalence of chronic pain has been shown to be high after thermal injury. Post-burn neuropathic pain causes chronic disabilities that is often difficult to treat effectively.

To study changes in the pain network associated with neuropathic pain, magnetic resonance imaging(MRI) will be used to evaluate cerebral blood volume(CBV) in patients who was injuried by burn. Over the fifty participants will be recruited. The participants will be comprised 30 subjects with neuropathic pain caused by thermal injury and 20 healthy contols. The 30 patients with neuropathic pain will be comprised divided into 15 electrical injury group and 15 non-electrical burn injury group. The patients are included the patients with severe neuropathic pain that is rated at least 5 on the visual analogue scale (VAS), despite treatments with gabapentin medication and other physical modalities. The intensity of neuropathic pain will be measured using the visual analogue scale(VAS). Depressive mood will be assessed using the Beck Depression Scale. CBV maps will be compared between burn patients and controls. And the relationship between individual participant CBV(measured in voxels), BDS and VAS score will be also examined.

Being tested
magnetic resonance imaging(MRI)
Keywords
burn, neuropathic pain, cerebral blood volume
Medical subject headings
Neuralgia, Burns

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • magnetic resonance imaging(MRI)Diagnostic test

    magnetic resonance imaging(MRI) will be used to evaluate cerebral blood volume(CBV) of pain network

Study groups in NCT04125576
Study groupRoleWhat they receive
Burn patientsThe subjects complaine of severe neuropathic pain that is rated at least 5 on the visual analogue scale (VAS), despite treatments with gabapentin medication and other physical modalities.
Receives: Diagnostic Test: magnetic resonance imaging(MRI)
Healthy controlsage and sex matched healthy controls
Receives: Diagnostic Test: magnetic resonance imaging(MRI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cerebral blood volume

    magnetic resonance imaging(MRI) was used to evaluate cerebral blood volume(CBV) of pain network

    Measured: 1 week

Secondary outcomes (1)
  1. visual analogue scale

    The intensity of neuropathic pain was measured using the visual analogue scale, Zero ("0") represented no pain and 10 represented unbearable symptoms

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2019
  2. Study start25 Oct 2019
  3. Primary completion15 Dec 2019 (estimated)
  4. Study completion20 Dec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT04125576
Sponsor's protocol ID
HangangSHH-5
Status last verified
Oct 2019
First submitted
10 Oct 2019
Last updated
14 Nov 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Park CH, Seo CH, Jung MH, Joo SY, Jang S, Lee HY, Ohn SH. Investigation of cognitive circuits using steady-state cerebral blood volume and diffusion tensor imaging in patients with mild cognitive impairment following electrical injury. Neuroradiology. 2017 Sep;59(9):915-921. doi: 10.1007/s00234-017-1876-1. Epub 2017 Jul 8.

    PubMed 28689261
  • Seo CH, Park CH, Jung MH, Jang S, Joo SY, Kang Y, Ohn SH. Preliminary Investigation of Pain-Related Changes in Cerebral Blood Volume in Patients With Phantom Limb Pain. Arch Phys Med Rehabil. 2017 Nov;98(11):2206-2212. doi: 10.1016/j.apmr.2017.03.010. Epub 2017 Apr 6.

    PubMed 28392326

Questions about this trial

What is this clinical trial studying?

An observational study of Neuropathic Pain, run by Hangang Sacred Heart Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cheong Hoon Seo, Dr. (+82 2 2639 5738, chseomd@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cerebral blood volume (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04125576, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in